This entry passed through the Full-Text RSS service - if this is your content and you're reading it on someone else's site, please read the FAQ at http://ift.tt/jcXqJW.
Wednesday 30 Dec 2015 - 12:17 Makkah mean time-19-3-1437
Detecting the early presence of cancer (EFE file image)
Mexico City (IINA) – A team of Mexican researchers is preparing for clinical trials of a treatment to prevent the recurrence of different types of cancers by prompting the immune system into action.
The new therapy "trains the immune system to recognize and eliminate remaining cancerous cells" after conventional treatment, team leader Dr Juan Pablo Márquez Manriquez, of the International Cancer Center in Sonora, told Spanish international news agency EFE.
Although the treatment is referred to as a vaccine, he said it was comprised of "a number of vaccines mixed together, like in a cocktail, which are specifically designed to fight against several neoplasms simultaneously."
"The animals that received the vaccine, both individual vaccines and the cocktail, never developed colon, pancreatic or ovarian cancer," Dr Márquez affirmed.
The studies have shown that the vaccine does not cause an auto-immune reaction or toxicity, he added. Márquez indicated that the next step is clinical trials, which will be conducted after federal regulators approve the protocol in January or February. “If the treatment becomes available for the public, we will have fewer recurrences, fewer hospitals full of patients with recurrent cancer and less palliative care, patients will suffer less pain or will have a life or a death with less suffering," he said.
AB/IINA
|
No comments:
Post a Comment